Markus from Hong Kong

Registered at the short selling broker Capital, 4 minutes ago.

» Try Capital you too
67.7% of retail investor accounts lose money when trading CFDs with Capital.
Don't show again

Reata Pharmaceuticals, Inc. (RETA) shares information

Reata Pharmaceuticals Inc – Class A


24h Change

-2.33 %

RETA

Live rate:

Stock data per Wednesday 5 Oct, 2022

RETA
NASDAQ
25.52
24.93
-0.595 (-2.33%)
US Market is open

Live Stock price in graph for Reata Pharmaceuticals Inc – Class A (RETA)

Data updated continously for RETA, showing up to the 500 most recent 100 data points

  • Latest Volume

    111,769 (-72.58 %)

  • Volume prev. day

    407,561

  • Avg. daily volume

    1,029,720

  • Market cap

    787,211,534

  • P/E ratio

    -2.98

  • Today high

    n/a

  • Today low

    n/a

  • 52 week high

    114.8 USD

  • 52 week low

    18.47 USD

  • YTD Change

    n/a

Quick links

 

Latest news about Reata Pharmaceuticals Inc – Class A

Below you can find the most recent news posts about Reata Pharmaceuticals Inc – Class A, primarily from US and UK based news sources.

Boom Or Bust: What Does The Future Hold For Reata Pharmaceuticals Inc. (NASDAQ: RETA) Stock?

Saturday, 1 October 2022, 21:00:00
Reata Pharmaceuticals Inc. (NASDAQ:RETA)’s traded shares stood at 0.58 million during the last session, with the company’s beta value hitting 1.14. At the close of trading, the stock’s price was $25.13, to imply an increase of 0.40% or $0.1 in intraday trading. The RETA share’s 52-week high remains $114.80, putting it -356.82% down since that … Boom Or Bust: What Does The Future Hold For Reata Pharmaceuticals Inc. (NASDAQ: RETA) Stock? Read More »
— Marketing Sentinel


Reata Pharmaceuticals Inc. (NASDAQ:RETA)’s 12-Month Price Target Currently Stands At $76.00

Saturday, 24 September 2022, 17:30:00
In last trading session, Reata Pharmaceuticals Inc. (NASDAQ:RETA) saw 0.63 million shares changing hands with its beta currently measuring 1.13. Company’s recent per share price level of $22.12 trading at -$1.94 or -8.06% at ring of the bell on the day assigns it a market valuation of $844.10M. That closing price of RETA’s stock is … Reata Pharmaceuticals Inc. (NASDAQ:RETA)’s 12-Month Price Target Currently Stands At $76.00 Read More »
— Marketing Sentinel


Alport Syndrome Market Is Expected To Grow During the Study Period (2019-2032), DelveInsight | Key Companies- Reata Pharmaceuticals, Regulus Therapeutics/ Sanofi Genzyme, and Several Others

Thursday, 22 September 2022, 02:35:19
“The increase in Alport Syndrome Market size is a direct consequence of an increase in R&D activity, increasing prevalent population, expected commercial success of upcoming therapies in the 7MM” The potential drugs recently launched in Alport Syndrome Market or expected to
— OpenPR


Reata Pharmaceuticals Inc. (NASDAQ: RETA): Down -75.91% In 2022, Outlook Remains Negative

Monday, 12 September 2022, 15:00:00
The trading price of Reata Pharmaceuticals Inc. (NASDAQ:RETA) closed lower on Friday, September 09, closing at $26.50, -2.11% lower than its previous close. Traders who pay close attention to intraday price movement should know that it fluctuated between $26.03 and $28.325. In examining the 52-week price action we see that the stock hit a 52-week … Reata Pharmaceuticals Inc. (NASDAQ: RETA): Down -75.91% In 2022, Outlook Remains Negative Read More »
— Stocks Register


Have you been able to find a good deal on Reata Pharmaceuticals Inc.’s shares?

Monday, 12 September 2022, 14:40:00
As of Friday, Reata Pharmaceuticals Inc.’s (NASDAQ:RETA) stock closed at $26.50, down from $27.07 the previous day. While Reata Pharmaceuticals Inc. has underperformed by -2.11%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, RETA fell by -75.91%, with highs and lows ranging from $114.80 to $18.47, […]
— US Post News


Trading broker recommendation

We recommend that you check out Capital.com as they have a very good selection of stocks available for both going short and long.

Rating: 9.57/10
Minimum deposit: €250 by bank
Description: Capital.com offer a large number of stocks for trading. Register an account today and check if they have RETA available or trade one of the many other CFD stocks they have.
Risk warning: 67.7% of retail investor accounts lose money when trading CFDs with Capital.